Two-week intervals during omalizumab treatment may provide better symptom control in selected patients with chronic urticaria
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, vol.6, no.4, pp.1389-1390, 2018 (SCI-Expanded, Scopus)
- Publication Type: Article / Letter
- Volume: 6 Issue: 4
- Publication Date: 2018
- Doi Number: 10.1016/j.jaip.2018.01.027
- Journal Name: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.1389-1390
- Erciyes University Affiliated: Yes